List of insiders holdings for TearLab Corp:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| CR Group L.P. CAPITAL ROYALTY PARTNERS II L.P. CAPITAL ROYALTY PARTNERS II - PARALLEL FUND (A) L.P. PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P. Capital Royalty Partners II Parallel Fund B (Cayman) L.P. 10% Owner | 2020-07-06 16:37:20 | 0 11,850,131 | 11,850,131 | Form 3 |
| Diamed Medizintechnik GmbH 10% Owner | 2004-12-08 18:34:30 | 4,332,234 0 | 4,332,234 | Form 3 |
| Wright Brock Director | 2017-02-13 17:08:58 | 1,059,522 0 | 1,059,522 | Form 5 |
| TLC VISION CORP 10% Owner | 2009-02-12 09:56:43 | 750,814 0 | 750,814 | Form 13G |
| Reeves Thomas Patrick President & COO | 2007-07-05 16:37:07 | 498,750 0 | 498,750 | Form 4 |
| Siegel Irving Z VP, Clinical Affairs | 2005-04-01 17:58:05 | 375,000 0 | 375,000 | Form 4 |
| Sullivan Benjamin Chief Science Officer | 2010-07-06 16:20:18 | 355,515 0 | 355,515 | Form 3 |
| Parks Stephen VP, Sales | 2007-07-05 16:03:45 | 330,000 0 | 330,000 | Form 4 |
| AWM Investment Company Inc. 10% Owner | 2018-02-13 14:40:11 | 263,863 0 | 263,863 | Form 13G |
| Cornish John Vice President, Operations | 2007-07-05 16:10:42 | 180,000 0 | 180,000 | Form 4 |
| Zawaideh Joseph Vice President, Sales | 2005-04-01 17:53:41 | 175,000 0 | 175,000 | Form 4/A |
| Eldridge David Craig VP, Science & Technology | 2007-07-05 16:57:54 | 171,722 0 | 171,722 | Form 4 |
| CALOZ JOHN Y Chief Financial Officer | 2005-06-02 12:21:44 | 162,500 0 | 162,500 | Form 3 |
| Fotheringham Julie Anne VP, Marketing | 2007-07-05 16:53:35 | 155,000 0 | 155,000 | Form 4 |
| Kilmer Stephen John VP, Investor & Public Affairs | 2007-07-05 16:46:56 | 155,000 0 | 155,000 | Form 4 |
| Adams Doug P President, Glaucoma Div. | 2007-07-05 17:02:23 | 130,000 0 | 130,000 | Form 4 |
| Noel Georges Director | 2007-07-05 17:06:38 | 117,500 0 | 117,500 | Form 4 |
| HOLMES JAY T Director | 2007-07-11 11:19:40 | 117,500 0 | 117,500 | Form 4 |
| Chaudry-Rao Nozait VP, Clinical Research | 2007-07-05 16:17:24 | 110,000 0 | 110,000 | Form 4 |
| Brazell Wes Chief Financial Officer | 2016-06-28 21:29:27 | 90,000 0 | 90,000 | Form 4 |
| OMENN GILBERT S Director | 2007-07-05 17:04:52 | 85,000 0 | 85,000 | Form 4 |
| LINDSTROM RICHARD L MD Director | 2020-03-12 16:38:36 | 60,000 0 | 60,000 | Form 4 |
| Kim Suh Won General Counsel and Secretary | 2008-10-20 20:27:38 | 50,168 0 | 50,168 | Form 4/A |
| Walder Robert Alan Vice President, Operations | 2013-03-08 20:24:10 | 30,000 0 | 30,000 | Form 4 |
| Graves Adrienne L Director | 2016-06-28 21:09:41 | 15,000 0 | 15,000 | Form 4 |
| Rindell Donald Clark Director | 2016-06-28 21:18:20 | 15,000 0 | 15,000 | Form 4 |
| Davidson Tom Jr. Director | 2016-06-28 21:27:40 | 15,000 0 | 15,000 | Form 4 |
| DAVIDSON TOM Director | 2010-10-05 12:23:20 | 1629 0 | 1629 | Form 4 |
| Barresi Barry J. Chief Executive Officer OcuHub | 2014-03-21 14:20:05 | 0 0 | 0 | Form 3 |
| Dumencu William Chief Financial Officer | 2013-09-03 17:54:00 | 0 0 | 0 | Form 4 |
| Donsky Eric Alan 10% Owner | 2013-08-08 13:04:17 | 0 0 | 0 | Form 13G |
| ALTIG ANTHONY E Director | 2020-07-09 16:03:25 | 0 0 | 0 | Form 4 |
| Jensen Joseph Chief Executive Officer | 2020-07-09 16:07:31 | 0 0 | 0 | Form 4 |
| Karpecki Paul Director | 2020-07-09 16:12:41 | 0 0 | 0 | Form 4 |
| Lindstrom Richard Director | 2020-07-09 16:14:13 | 0 0 | 0 | Form 4 |
| Marquez Michael Chief Financial Officer | 2020-07-09 16:15:34 | 0 0 | 0 | Form 4 |
| VAMVAKAS ELIAS Director | 2020-07-10 12:57:36 | 0 0 | 0 | Form 4 |